AbbVie Gets European Medicines Agency's Positive Opinion For Its IMBRUVICA
April 29, 2016 at 11:12 AM EDT
AbbVie Inc (NYSE: ABBV) disclosed that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...